Healthcare
Florida Mold Remediation Company Highlights Critical Warning Signs for Homeowners
FixMold, a Miami-based mold remediation specialist, identifies early warning signs of mold growth that Florida homeowners should never ignore, emphasizing the serious health and structural implications of untreated mold contamination.
NW Legacy Law Supports Ronald McDonald House Through Fundraising Initiative
NW Legacy Law's fundraising support for Ronald McDonald House Charities of Oregon & SW Washington demonstrates how legal firms can contribute to community welfare by assisting families with critically ill children during emotionally challenging times.
Headwaters Hospice Appoints Healthcare Veteran James Bisom as New CEO
Headwaters Hospice and Palliative Care has appointed James Bisom as its new Chief Executive Officer, bringing over 14 years of healthcare leadership experience to advance quality end-of-life care services across Montana.
New Book Offers Faith-Based Approach to Mental Health Challenges
Certified Life Coach Miss Walker's new book 'The Secret Formula of Amazing Hope' provides a structured three-step approach combining biblical principles with life coaching techniques to help individuals navigate stress, anxiety, and depression.
Olympus Launches Combined Imaging Mode to Enhance Cancer Detection Capabilities
Olympus Corporation has introduced a new NBI+TXI observation mode for its EVIS X1 endoscopy system that combines two advanced imaging technologies to improve detection and diagnostic accuracy for gastrointestinal and respiratory cancers, addressing Japan's high cancer incidence rates.
Medical Cannabis Access Linked to Reduced Opioid Use Among Cancer Surgery Patients
A new study reveals that states with medical cannabis dispensaries show decreased opioid prescriptions for cancer surgery patients but increased non-treatment hospital visits, highlighting the complex implications of cannabis policy on pain management and healthcare utilization.
Soligenix ThermoVax Technology Addresses Critical Vaccine Stability Challenge in Epidemic Response
Soligenix's development of thermostable vaccines that remain stable at high temperatures could significantly reduce global vaccine wastage and improve deployment in outbreak regions where cold chain infrastructure is limited.
HeartBeam Partners With HeartNexus to Expand Remote Cardiac Monitoring Services
HeartBeam's partnership with HeartNexus enables 24/7 remote cardiology services and real-time ECG interpretation, expanding access to medical-grade cardiac care outside traditional healthcare facilities.
Glioblastoma Remission Rates Remain Challenging Despite Treatment Advances
Only 25% of glioblastoma patients experience remission lasting at least two years, highlighting the urgent need for improved treatments for this aggressive brain cancer.
Lantern Pharma Reports Complete Response in AI-Driven Cancer Drug Trial
Lantern Pharma's AI-developed drug LP-284 achieved a complete metabolic response in a heavily pre-treated lymphoma patient, demonstrating the potential of artificial intelligence to accelerate oncology drug development and address critical treatment gaps.
Nutriband Advances Abuse-Deterrent Fentanyl Patch Toward FDA Submission Following Regulatory Feedback
Nutriband Inc. has received critical FDA guidance confirming the regulatory pathway for its AVERSA™ Fentanyl abuse-deterrent transdermal system, marking a significant step forward in addressing the opioid crisis through innovative pharmaceutical technology.
Oncotelic's Nanomedicine Platform Advances Cancer Treatment Through Enhanced Drug Delivery
Oncotelic Therapeutics' Deciparticle platform represents a significant advancement in nanomedicine that improves drug bioavailability and therapeutic effectiveness in oncology treatments.
New IDSA Guidelines Highlight Critical Need for Tailored COVID-19 Vaccines for Immunocompromised Population
GeoVax's GEO-CM04S1 vaccine addresses the significant protection gap for over 40 million immunocompromised Americans who experience limited effectiveness from current COVID-19 vaccines, as highlighted by new Infectious Diseases Society of America guidelines.
Circadian Rhythm Disruptions Linked to Increased Cardiometabolic Disease Risk, American Heart Association Warns
The American Heart Association's new scientific statement reveals that disruptions to the body's internal clock significantly increase risks for obesity, Type 2 diabetes, high blood pressure and cardiovascular disease, highlighting the importance of circadian alignment for preventive health strategies.
Heart To Beat Forms Strategic Partnership to Expand Life-Safety Services Nationwide
Heart To Beat's new ownership partnership with three business leaders will accelerate the company's growth and expand its life-saving safety services to more organizations across the United States.
FDA Clears First 4-in-1 Home Test for RSV, Flu, and COVID Detection
ACON Laboratories has received FDA clearance for the first over-the-counter home test that simultaneously detects RSV, influenza A, influenza B, and COVID-19, representing a significant advancement in consumer respiratory health monitoring.
Natural Cure Labs Updates Level Off Supplement with Loquat Leaf Extract for Enhanced Metabolic Support
Natural Cure Labs has reformulated its Level Off metabolic support supplement with loquat leaf extract, demonstrating improved performance in maintaining healthy post-meal glucose levels for adults seeking practical wellness solutions.
Dr. Hos Loftus Earns 2025 Castle Connolly Top Doctor Recognition for Integrated Neurology and Psychology Care
Dr. Hos Loftus has been recognized as a 2025 Castle Connolly Top Doctor for his innovative integrated approach to neurological and psychological care at Carolinas Institute for Neurology and Psychology, highlighting the growing importance of holistic treatment models in modern healthcare.
La Posada Book Club Demonstrates Cognitive and Social Benefits for Seniors During National Book Month
A thriving book club at La Posada retirement community shows how reading and social engagement provide significant cognitive and emotional benefits for older adults, supported by research from leading health organizations.
The IMA Group Marks 35 Years of Growth from Medical Evaluations to Clinical Research Network
The IMA Group has evolved from medical screening services into a national clinical research organization with 150 locations, demonstrating how healthcare companies can successfully expand while maintaining quality standards.
Datavault AI Partners with Wellgistics to Develop Blockchain PharmacyChain System
Datavault AI's collaboration with Wellgistics to create PharmacyChain smart contracts could transform pharmaceutical logistics through enhanced transparency and efficiency in the $639 billion prescription drug market.
Octane's 2025 Medical Innovation Forum to Spotlight Health Longevity Breakthroughs
Southern California's premier innovation accelerator Octane will host its 2025 Medical Innovation Forum featuring groundbreaking longevity research and wellness innovations that could transform future healthcare approaches.
PetVivo Holdings to Showcase Veterinary Medical Innovations at Spartan Capital Investor Conference
PetVivo Holdings will present its innovative veterinary medical devices at the Spartan Capital Securities investor conference, highlighting the company's growth potential in the animal healthcare market.
Nanomedicine Breakthroughs Transform Cancer Drug Delivery and Bioavailability
Recent advancements in nanomedicine technology are revolutionizing oncology treatment by improving drug delivery systems, enhancing bioavailability, and potentially transforming underperforming cancer drugs into effective therapies through platforms like Oncotelic Therapeutics' Deciparticle.
Study Reveals Chemotherapy May Damage Brain's Waste Drainage System, Explaining 'Chemo Brain' Symptoms
New research identifies chemotherapy-induced damage to the brain's waste drainage network as a potential cause of cognitive difficulties affecting up to 75% of cancer patients during and after treatment.
Nutriband Founder Returns as CEO to Lead Final Development of Abuse-Deterrent Fentanyl Patch
Nutriband founder Gareth Sheridan has resumed his role as CEO to lead the final development phase of AVERSA Fentanyl, an abuse-deterrent opioid patch with potential peak annual U.S. sales estimated between $80 million and $200 million.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic
Aditxt's subsidiary Pearsanta has begun enrolling patients in a clinical study for a novel blood-based endometriosis test that could provide earlier, non-invasive detection compared to current surgical methods.
Izotropic Corporation Advances 3D AI-Imaging Technology in Growing $9 Billion Market
Izotropic Corporation is developing the IzoView Breast CT Imaging System, which combines high-resolution volumetric imaging with proprietary AI reconstruction to enhance breast cancer detection capabilities in a rapidly expanding medical imaging market.
NanoViricides to Present Antiviral Pipeline Updates at PODD 2025 Conference
NanoViricides will showcase its broad-spectrum antiviral drug platform at the upcoming PODD 2025 conference, highlighting progress toward Phase II trials for its lead candidate NV-387 targeting multiple respiratory viruses and MPox.
Branded Legacy Advances Engineering of Air-Driven Intranasal Drug Delivery Platform
Branded Legacy's subsidiary BioLegacy Evaluative Group has begun engineering a unitary device mold for its proprietary air-driven intranasal drug delivery system, marking a significant step toward scalable production of affordable addiction treatment solutions including inhaled naloxone.